JP2016502523A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016502523A5 JP2016502523A5 JP2015542272A JP2015542272A JP2016502523A5 JP 2016502523 A5 JP2016502523 A5 JP 2016502523A5 JP 2015542272 A JP2015542272 A JP 2015542272A JP 2015542272 A JP2015542272 A JP 2015542272A JP 2016502523 A5 JP2016502523 A5 JP 2016502523A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- human mammal
- rfsh
- analog
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283690 Bos taurus Species 0.000 claims 9
- 230000003325 follicular Effects 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 230000001850 reproductive effect Effects 0.000 claims 6
- 230000009027 insemination Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 230000016087 ovulation Effects 0.000 claims 5
- 239000000583 progesterone congener Substances 0.000 claims 4
- 150000003180 prostaglandins Chemical class 0.000 claims 4
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 210000000287 oocyte Anatomy 0.000 claims 3
- 101800005309 Carboxy-terminal peptide Proteins 0.000 claims 2
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 claims 2
- 238000010255 intramuscular injection Methods 0.000 claims 2
- 239000007927 intramuscular injection Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 206010042573 Superovulation Diseases 0.000 claims 1
- 238000002679 ablation Methods 0.000 claims 1
- 102000002287 alpha Subunit Glycoprotein Hormones Human genes 0.000 claims 1
- 108010000732 alpha Subunit Glycoprotein Hormones Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000035824 beta Subunit Follicle Stimulating Hormone Human genes 0.000 claims 1
- 108010081485 beta Subunit Follicle Stimulating Hormone Proteins 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 244000144980 herd Species 0.000 claims 1
- 230000003054 hormonal effect Effects 0.000 claims 1
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306428.9A EP2732824A1 (en) | 2012-11-16 | 2012-11-16 | Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone |
| EP12306428.9 | 2012-11-16 | ||
| PCT/EP2013/073928 WO2014076231A1 (en) | 2012-11-16 | 2013-11-15 | Single dose recombinant bovine fsh after follicular synchronisation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018129177A Division JP6823013B2 (ja) | 2012-11-16 | 2018-07-06 | 卵胞同期化後の単回リコンビナントウシfsh |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016502523A JP2016502523A (ja) | 2016-01-28 |
| JP2016502523A5 true JP2016502523A5 (enExample) | 2016-12-22 |
| JP6419707B2 JP6419707B2 (ja) | 2018-11-07 |
Family
ID=47221997
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542272A Active JP6419707B2 (ja) | 2012-11-16 | 2013-11-15 | 卵胞同期化後の単回リコンビナントウシfsh |
| JP2018129177A Active JP6823013B2 (ja) | 2012-11-16 | 2018-07-06 | 卵胞同期化後の単回リコンビナントウシfsh |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018129177A Active JP6823013B2 (ja) | 2012-11-16 | 2018-07-06 | 卵胞同期化後の単回リコンビナントウシfsh |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150335713A1 (enExample) |
| EP (3) | EP2732824A1 (enExample) |
| JP (2) | JP6419707B2 (enExample) |
| CN (2) | CN110433281A (enExample) |
| AU (1) | AU2013346803B2 (enExample) |
| ES (1) | ES2743763T3 (enExample) |
| MX (1) | MX373765B (enExample) |
| RU (1) | RU2679944C2 (enExample) |
| WO (1) | WO2014076231A1 (enExample) |
| ZA (1) | ZA201503404B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2782584T3 (pl) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Naturalne skojarzone hormonalne formulacje i terapie zastępcze |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| MX2016014281A (es) | 2014-05-22 | 2017-02-22 | Therapeuticsmd Inc | Formulaciones y terapias de reemplazo de combinación de hormonas naturales. |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| CN105727260A (zh) * | 2016-02-03 | 2016-07-06 | 华侨大学 | 一种卵泡刺激素的长效制剂 |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| US11376220B2 (en) | 2017-06-30 | 2022-07-05 | Therio, LLC | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals |
| CN107173329A (zh) * | 2017-07-07 | 2017-09-19 | 宣汉县蜀宣花牛养殖专业合作社 | 一种蜀宣花牛母牛繁殖方法 |
| CL2018001347A1 (es) * | 2018-05-18 | 2019-03-15 | Centro De Biotecnologia Y Biomedicina Spa 94% | Hormona folículo estimulante bovina recombinante, composición que la comprende y método para inducir superovulación y sincronización del celo en bovinos utilizando dicha hormona |
| CN114258302A (zh) * | 2019-08-01 | 2022-03-29 | 法国诗华大药厂 | 用于预防和/或治疗隐孢子虫病的兽用组合物 |
| EP4504238A1 (en) | 2022-04-01 | 2025-02-12 | Ceva Santé Animale | Increase of ovum pick-up in bos taurus |
| WO2023187160A1 (en) | 2022-04-01 | 2023-10-05 | Ceva Sante Animale | Stimulation of superovulation in bos taurus |
| CN116027053B (zh) * | 2022-09-27 | 2024-10-08 | 华中农业大学 | 一种竞争型草鱼卵泡刺激素检测试剂盒及应用 |
| CN117089512A (zh) * | 2023-08-21 | 2023-11-21 | 山东奥克斯畜牧种业有限公司 | 一种促进卵泡同步发育的制剂及牛体外胚胎生产方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1729352A1 (ru) * | 1987-11-25 | 1992-04-30 | Украинский Научно-Исследовательский Институт Физиологии И Биохимии Сельскохозяйственных Животных | Способ вызывани полиовул ции у коров-доноров при трансплантации эмбрионов |
| US6238890B1 (en) | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
| US5589457A (en) | 1995-07-03 | 1996-12-31 | Ausa International, Inc. | Process for the synchronization of ovulation |
| JPH09104638A (ja) * | 1995-10-06 | 1997-04-22 | Mitsui Pharmaceut Inc | 医薬・動物薬組成物 |
| US20090036384A1 (en) | 2005-12-02 | 2009-02-05 | Parnell Laboratories (Aust) Pty Limited | Increasing pregnancy rates |
| US8518881B2 (en) | 2007-02-08 | 2013-08-27 | Aspenbio Pharma, Inc. | Methods for inducing superovulation in ungulates |
| BRPI0821097A2 (pt) | 2007-11-30 | 2017-05-23 | Aspenbio Pharma Inc | aitividade de hormônio equino folículo estimulante recombinante |
| WO2009103965A1 (en) * | 2008-02-19 | 2009-08-27 | Asterion Limited | Modified linkers |
| JP5435422B2 (ja) * | 2009-07-21 | 2014-03-05 | 独立行政法人農業・食品産業技術総合研究機構 | ウシの発情同期化法およびそのためのキット |
-
2012
- 2012-11-16 EP EP12306428.9A patent/EP2732824A1/en not_active Withdrawn
-
2013
- 2013-11-15 MX MX2015006141A patent/MX373765B/es active IP Right Grant
- 2013-11-15 JP JP2015542272A patent/JP6419707B2/ja active Active
- 2013-11-15 WO PCT/EP2013/073928 patent/WO2014076231A1/en not_active Ceased
- 2013-11-15 EP EP13791813.2A patent/EP2919803B1/en active Active
- 2013-11-15 ES ES13791813T patent/ES2743763T3/es active Active
- 2013-11-15 CN CN201910624749.6A patent/CN110433281A/zh active Pending
- 2013-11-15 AU AU2013346803A patent/AU2013346803B2/en active Active
- 2013-11-15 RU RU2015122887A patent/RU2679944C2/ru active
- 2013-11-15 EP EP19151721.8A patent/EP3520807A1/en not_active Withdrawn
- 2013-11-15 CN CN201380060063.XA patent/CN104918631A/zh active Pending
- 2013-11-15 US US14/443,193 patent/US20150335713A1/en not_active Abandoned
-
2015
- 2015-05-15 ZA ZA2015/03404A patent/ZA201503404B/en unknown
-
2018
- 2018-07-06 JP JP2018129177A patent/JP6823013B2/ja active Active
-
2019
- 2019-03-21 US US16/360,285 patent/US20190200587A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016502523A5 (enExample) | ||
| RU2015122887A (ru) | КОМПОЗИЦИИ И СПОСОБЫ ПОВЫШЕНИЯ РЕПРОДУКТИВНОЙ АКТИВНОСТИ У МЛЕКОПИТАЮЩИХ, НЕ ЯВЛЯЮЩИХСЯ ЧЕЛОВЕКОМ, С ПРИМЕНЕНИЕМ БИОЛОГИЧЕСКИ АКТИВНОГО РЕКОМБИНАНТНОГО ФОЛЛИКУЛОСТИМУЛИРУЮЩЕГО ГОРМОНА (rFSH) | |
| EP2134165B1 (en) | Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone | |
| Martemucci et al. | Induction/synchronization of oestrus and ovulation in dairy goats with different short term treatments and fixed time intrauterine or exocervical insemination system | |
| Sanderson et al. | A single administration of a long-acting recombinant ovine FSH (roFSH) for cattle superovulation | |
| US8835386B2 (en) | Activity of recombinant equine follicle stimulating hormone | |
| US20220143131A1 (en) | Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone | |
| RU2021134549A (ru) | Композиции и способы повышения репродуктивной способности у млекопитающих, не относящихся к человеку, с помощью рекомбинантного лютеинизирующего гормона | |
| RU2024128835A (ru) | Стимуляция суперовуляции у bos taurus | |
| RU2024128836A (ru) | Увеличение захвата яйцеклеток у коров bos taurus | |
| JP2020525547A (ja) | 雌動物において複数の卵胞を誘発および制御するための単回注射方法および製剤 | |
| Vela et al. | Uses of prostaglandins | |
| Cho et al. | Efficacy of a Cue-Mate Intravaginal Insert and Injection of Prostaglandin F2α for Synchronizing Estrus in Hanwoo Cattle | |
| Alemayehu et al. | A study on the efficiency of natural and synthetic prostaglandins for estrus synchronization in Jennies | |
| COWIE | rat (41, 42). Using hypophysectomized, or hypophysectomized-ovariec-tomized (doubly operated) or hypophysectomized-ovariectomized-ad | |
| ES2683868A1 (es) | Dinoprost Trometamina para incrementar la probabilidad de gestación en terneras |